Dr. Flaifel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
550 1st Avenue
New York, NY 10016- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematopathology, 2023 - 2025
- NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 2019 - 2023
- Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Research, 2017 - 2019
- American University of Beirut Faculty of MedicineClass of 2016
Certifications & Licensure
- MD State Medical License 2022 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 3 citationsSignificance of the Percentage of Gleason Pattern 4 at Prostate Biopsy in Predicting Adverse Pathology on Radical Prostatectomy: Application in Active Surveillance.Jeffrey Ordner, Abdallah Flaifel, Antonio Serrano, Rebecca Graziano, Jonathan Melamed, Fang-Ming Deng> ;American Journal of Clinical Pathology. 2023 Jul 5
- 7 citationsEpigenomic charting and functional annotation of risk loci in renal cell carcinoma.Amin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, Elio Adib, Rosario I Corona, Ji-Heui Seo, Marcos A S Fonseca, Sandor Spisak, Talal El Zarif, Viktoria Tisza, David A B...> ;Nature Communications. 2023 Jan 21
- 4 citationsBiomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial.Thomas Denize, Subrina Farah, Alessia Cimadamore, Abdallah Flaifel, Emily Walton, Maura A Sticco-Ivins, David A Braun, Maxine Sun, Evelyn Wang, Wanling Xie, Toni K Cho...> ;Clinical Cancer Research. 2022 Feb 15
- Join now to see all
Press Mentions
- Immune system changes occur early in development of multiple myeloma, study findsSeptember 25th, 2020
- ASCO 2019: Efficacy of Immune Checkpoint Inhibitors and Genomic Characterization of Sarcomatoid and/or Rhabdoid Metastatic Renal Cell CarcinomaSeptember 25th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: